IKS Healthcare, a health-tech company backed by the family of late investor Rakesh Jhunjhunwala, is in talks to acquire US-based TruBridge for around $600 million. The potential deal, if finalised, would be one of the largest moves by the company as it looks to grow its presence in the United States.
IKS Healthcare provides technology and administrative support services to healthcare providers, helping them manage operations like billing and patient data. By acquiring TruBridge, the company hopes to strengthen its offerings, especially in serving hospitals and healthcare systems in the US.
TruBridge is known for providing healthcare IT solutions and revenue cycle management services, particularly to smaller and mid-sized hospitals. The acquisition could help IKS expand its client base and build a more comprehensive range of services by combining the strengths of both companies.
Reports suggest that IKS is planning to fund the deal through an all-cash transaction and is in discussions with global banks to raise financing. The funds would likely be used not only for the acquisition but also to manage TruBridge’s existing debt.
However, the deal is not yet final. IKS has clarified that discussions are ongoing and that no binding agreement has been signed so far. This means the acquisition is still subject to negotiations, regulatory approvals, and other conditions.
The move reflects a broader trend in the healthcare technology sector, where companies are expanding through acquisitions to scale up and stay competitive. For IKS, entering deeper into the US market could open up new growth opportunities and strengthen its position globally.
If the deal goes through, it would mark a significant milestone for the company and highlight the growing ambitions of Indian health-tech firms on the global stage.
Also Read: PPF plan builds ₹1 crore, ₹61,000 income